Docusign SEC Filings

Initial Form 3 for DocuSign, Inc. (DOCU) reports that Michael George Rosenbaum filed as a director with an event date of 09/03/2025. The filing states no securities are beneficially owned by the reporting person at the time of the statement. The form was signed by an attorney-in-fact on 09/10/2025.

DocuSign reported interim results for the quarter ended July 31, 2025, emphasizing subscription-driven revenue and continued investment in its platform. Subscriptions represented approximately 98% of revenue for the three and six months ended July 31, 2025, and the company reported $2.3 billion of transaction price allocated to remaining performance obligations, with 57% expected to be recognized within 12 months. DocuSign serves over 1.7 million customers and more than a billion users worldwide. Contract assets were $9.9 million as of July 31, 2025. Information technology costs rose, increasing $7.7 million in the three-month period and $14.5 million for the six months ended July 31, 2025, reflecting cloud migration. The company repurchased 4.9 million shares for $384.9 million during the six months and has $1.2 billion of remaining repurchase authorization. DocuSign had a credit facility of $750 million with a $250 million accordion maturing in May 2030 and reported no outstanding borrowings under it as of July 31, 2025. The filing discloses ongoing securities and derivative litigation related to prior-period statements and continued valuation allowances for certain deferred tax assets.

DocuSign director Anna Marrs received 725 restricted stock units (RSUs) on 09/04/2025, reported on a Form 4. After the grant, she beneficially owns 11,527 shares of DocuSign common stock. The RSUs carry a $0 purchase price and represent contingent rights to one share each. They vest in twelve equal quarterly installments over three years beginning June 4, 2023, conditioned on continued service, and do not expire prior to vesting.

DocuSign, Inc. reported results for the three and six months ended July 31, 2025 via a press release furnished as Exhibit 99.1 to this Current Report. The Company announced the appointment of Mike Rosenbaum to the Board effective September 3, 2025 as a Class III director whose term expires at the Company’s 2027 Annual Meeting of Stockholders. The Board determined Mr. Rosenbaum is an independent director, there are no arrangements or related‑party interests requiring disclosure, and he will receive compensation under the Company’s existing Amended and Restated Director Compensation Program. Mr. Rosenbaum has also entered the Company’s standard indemnity agreement. The press release also announces James Beer as Board Chair; these disclosures are furnished under Regulation FD and are not "filed" for Section 18 liability.

Enrique T. Salem, a director of DocuSign, Inc. (DOCU), reported acquisitions on August 29, 2025. The filing shows Mr. Salem received 729 shares of common stock and 729 restricted stock units (RSUs) at a $0.00 price as part of an equity grant. After the transaction he beneficially owns 165,131 shares. The RSUs have a vesting commencement date of May 29, 2025 and vest in equal quarterly installments over one year, with the fourth installment subject to earlier vesting at the company’s next annual meeting or the one-year anniversary. The RSUs do not expire.

DocuSign director Anna Marrs was granted equity on 08/29/2025 consisting of 729 restricted stock units (RSUs) that convert one-for-one into common shares upon vesting. The RSUs were reported with a $0 price and have a vest commencement date of May 29, 2025, vesting in equal quarterly installments over one year, with the fourth installment accelerating to the earlier of the next annual meeting or the one-year anniversary, subject to continued service. After the reported transactions, the Form 4 shows 10,802 shares of common stock beneficially owned and 2,187 RSUs outstanding for the reporting person.

DocuSign director Teresa Briggs received a grant of 729 restricted stock units on 08/29/2025, each RSU representing the contingent right to one share of DocuSign common stock. The reported transactions show 729 RSUs acquired at a reported price of $0 and an increase in directly held common stock to 9,534 shares. Following the grant, the reporting person beneficially owns 2,187 RSUs that convert into common shares if they vest. The RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, with the fourth installment accelerating to the earlier of the company’s next annual meeting or the one-year anniversary, subject to continued service. The RSUs do not expire.

Mary Agnes Wilderotter, a director of DocuSign, Inc. (DOCU), received a grant of 729 restricted stock units (RSUs) on 08/29/2025. Each RSU converts to one share of common stock when vested. After the grant, the filing reports 58,345 shares beneficially owned by Ms. Wilderotter in common stock and 2,187 RSUs beneficially owned in derivative form. The RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, with the fourth installment potentially accelerating to the earlier of the next annual meeting or the one-year anniversary, subject to continued service. The RSUs do not expire and are either vested or canceled prior to vesting.

Director Hayes Cain A received equity awards tied to DocuSign, Inc. common stock on 08/29/2025. The filing reports an acquisition of 729 restricted stock units (RSUs) that represent the right to one share each and a separate line showing 729 shares of common stock acquired at $0. After the transactions, the reporting person is shown as beneficially owning 13,530 shares of common stock (direct) and 2,187 RSUs (derivative) following the reported transactions. The RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, with the fourth installment accelerating to the earlier of the next annual meeting or the one-year anniversary, subject to continued service. The RSUs do not expire.